About the Intravenous Solutions Market
The infusion of liquid substances, such as nutrients and drugs, directly into a vein is referred as intravenous therapy. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses. These fluids are dispensed in volumes ranging from 25-1,000 milliliters and are available in either plastic bags or glass bottles. A complete mixture of all essential nutrients is also available in multi-chamber bags, and these bags are gaining immense popularity among numerous end-users.
Technavio’s analysts forecast the global intravenous solutions market to grow at a CAGR of 5.79% during the period 2016-2020.Covered in this report The report covers the present scenario and the growth prospects of the global intravenous solutions market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of various type intravenous fluids:
Technavio Announces the Publication of its Research Report – Global Intravenous Solutions Market 2016-2020
Technavio recognizes the following companies as the key players in the Global Intravenous Solutions Market: Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, and Hospira Inc.
Other Prominent Vendors in the market are: Bioscrip, Claris Lifesciences, Grifols, IV Solutions, JW Life Science, Sichuan Kelun Pharmaceutical, Terumo, Thai Otsuka Pharmaceutical, Omnicare, Vifor Pharma, and Widatra Bhakti.
Commenting on the report, an analyst from Technavio’s team said: “The rising popularity of intravenous vitamin C therapy in cancer treatment is one of the major trends in the market. The intravenous vitamin C solution has been observed to have an increased toxicity to cancer cells and improve the patients' quality of life.”
According to the report, the growth of the global intravenous solutions market is driven by several factors. The increasing incidence of gastrointestinal disorders, diabetes, and cancer is one of the major factors that is expected to increase the rate of adoption of intravenous solutions among consumers.
Further, the report states that the presence of stringent regulations introduced by governments leads to unnecessary delays and additional costs in manufacturing. This hinders the growth of the vendors and, therefore, the market.
Baxter, B. Braun Melsungen AG, Fresenius Kabi AG, Hospira Inc, Bioscrip, Claris Lifesciences, Grifols, IV Solutions, JW Life Science, Sichuan Kelun Pharmaceutical, Terumo, Thai Otsuka Pharmaceutical, Omnicare, Vifor Pharma, Widatra Bhakti.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook